BioHealth News Archive
The GSK way: make hard-to-mimic drugs and don’t worry about patents – Quartz
GlaxoSmithKline (GSK), the British pharmaceutical company, reported lackluster fourth quarter earnings for 2012 this morning, with a 3.5% drop in revenue. But the company’s performance…
Read More
Q&A: Rep. Mike Honda on Proposed FDA Office of Wireless Health – Venture Capital Dispatch – WSJ
Congressman Michael Honda (D., Calif.), who has been representing Silicon Valley in the U.S. House of Representatives for the past 12 years, recently submitted a…
Read More
Economic Development Authority Director to Brief White House – HCEDA
Julie Lenzer Kirk, Executive Director of the Howard County Economic Development Authority’s Maryland Center for Entrepreneurship and Co-Chair of Startup Maryland, will brief White…
Read More
Catabasis rakes in $8M fundraise – Boston Business Journal
Clinical stage biopharmaceutical company Catabasis Pharmaceuticicals Inc. has pulled in an $8.7 million round of funding, according to federal documents. This is the not…
Read More
Post-Phase II SBIR grants could mean extra millions for your research
There’s a special place in NIH’s heart for SBIR research to develop drugs, medical devices and other products that require FDA approval. For these…
Read More
A new model for hospital collaboration & innovation: Nonprofit systems fund stand-alone Innovation Institute – MedCity News
As hospitals work to boost their efficiency and the quality of care they deliver, many are finding they need new ways to go about…
Read More
Tech Transfer Speakers: The New TEDCO: Changes to Our Funding Programs
The next event in Tech Transfer Speaker Series will be taking place on February 13, 2013 in the William E. Hanna, Jr. Innovation Center (9700…
Read MoreShow Me the Money – Perspectives of VCs, Private Equity and Angel Investors – SoPE Events
Whether you are a budding life science entrepreneur or potential investor, this event should be of interest to you. Multiple speakers explain how to…
Read More
AdvaMed2013 – The MedTech Conference – Washington, DC
After its outstanding success in Boston in 2012, AdvaMed 2013: The MedTech Conference is back in our nation's capital, Washington, DC. AdvaMed 2013 is…
Read More
BiotechBlog | Which pharmaceutical companies face the most patent expirations this year? – BiotechBlog
This infographic from DrugPatentWatch shows that Sanofi Aventis, Merck, and GlaxoSmithKline face the most patent expirations this year. Perhaps not surprisingly, GlaxoSmithKline and Sanofi…
Read More
Funding for Health Startups: SBIR awardee discussion – Blue Button for America
Blue Button Plus (Automated and Interoperable Blue Button) can provide a technology path for startups and innovators to build new products and services to…
Read More
Got A Superbug? Bring In The Robots – WBUR & NPR
Drug-resistant bacteria are a growing problem at hospitals across the country. The bacteria, such as Staphylococcus and Clostridium difficile, are difficult to prevent and…
Read More
What’s in a Name? A Lot, When It Comes to ‘Precision Medicine’ – Xconomy
Personalized medicine was supposed to be the pot of gold at the end of the rainbow. It was going to be the payoff our…
Read More
NEA expands its footprint – Washington Business Journal
New Enterprise Associates Inc. is likely to open a Boston office within the next half a year, General Partner David Mott told the Boston…
Read More
Maryland eyes greater ownership in program’s venture capital firms – Gazette.Net
State officials are seeking some changes in the $84 million InvestMaryland program, including allowing the Department of Business and Economic Development to acquire a…
Read More